abstract |
Antibody binding molecules, chimeric receptors, and engineered immune cells for FLT3 in accordance with the present invention are disclosed. The invention also relates to vectors, compositions, and methods of treatment and / or detection using FLT3 antigen binding molecules and genetically engineered immune cells. |